Consistent with previous studies, ARTS in combination with dFdC inhibited DMBA-induced pancreatic cancer in mice (Figure 6), implying that ARTS could overcome dFdC resistance in pancreatic cancer by suppressing c-Myc and PD-L1 expression. The gene discussed is MYC; the disease is familial pancreatic carcinoma.